Latest Innovation News

SEEK Limited reported robust H1 FY2026 results, powered by AI-driven product innovation and pricing, delivering strong revenue and profit growth alongside a record interim dividend. However, a significant impairment on its Zhaopin investment weighed on reported earnings.

SEEK Limited has reported a robust first half for FY2026, driven by AI-enhanced products and strategic pricing, resulting in double-digit revenue growth and a record interim dividend.

SEEK Limited posted strong half-year revenue growth and record dividends, but a hefty impairment charge on its Chinese associate Zhaopin led to a significant net loss. The company’s strategic platform unification and Sidekicker reacquisition underpin operational momentum despite macroeconomic headwinds.

Tetratherix Limited reveals promising interim results for TetraDerm, its scar prevention product, showing minimal scarring in patients after skin lesion surgeries. The product’s unique approach could reshape wound closure in a $US2.1 billion market.

Baby Bunting reported a 6.7% rise in revenue to $271.4 million for H1 2026, while statutory net profit after tax fell 52.5%. Adjusted earnings paint a steadier picture with a 4.1% increase in pro forma NPAT.

Smart Parking Limited has reported record first-half results for FY26, driven by strong organic growth and a successful US acquisition that boosted earnings per share by over 30%.

Judo Bank has reported a robust half-year result with profit before tax surging 53% year-on-year, driven by strong SME loan growth and improved operating efficiency. The bank reaffirms its FY26 guidance, signalling confidence in continued momentum.

Prominence Energy has begun preparatory work for its first geochemical survey in South Australia's PEL 803, aiming to detect natural hydrogen and helium as part of the Gawler Hydrogen Project.

Challenger reports a solid first half of FY26 with rising profits, strong annuity sales, and strategic partnerships, underpinning a confident outlook and a $150 million share buy-back plan.

Challenger Limited reported a solid first half of FY26 with a 2% rise in normalised net profit after tax and record annuity sales. The company also announced a $150 million on-market share buy-back, reflecting confidence in its strong capital position.

Osteopore Limited has drawn down the second tranche of its redeemable convertible notes, raising A$500,000 as part of a broader A$20 million funding agreement with Advance Opportunities Fund. The funds are earmarked to support ongoing operations and future growth initiatives.

Qualitas Limited reports robust interim results for the six months to December 2025, driven by strong deployment and expanding investor mandates, reaffirming its FY26 guidance.